DA
CVS icon

Dillon & Associates’s CVS Health CVS Stock Holding History

Dillon & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,160
Closed -$258K – 70
2018
Q1 		$258K Sell
4,160
-300
-7% -$21.5K 0.1% 62
2017
Q4 		$321K Sell
4,460
-85
-2% -$6.18K 0.12% 60
2017
Q3 		$368K Sell
4,545
-830
-15% -$65.7K 0.15% 57
2017
Q2 		$430K Sell
5,375
-4,895
-48% -$387K 0.18% 54
2017
Q1 		$801K Sell
10,270
-1,005
-9% -$80.2K 0.34% 44
2016
Q4 		$891K Buy
11,275
+2,340
+26% +$189K 0.41% 40
2016
Q3 		$795K Buy
8,935
+3,610
+68% +$341K 0.37% 45
2016
Q2 		$511K Buy
5,325
+2,940
+123% +$293K 0.23% 53
2016
Q1 		$248K Buy
+2,385
New +$232K 0.12% 63

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dillon & Associates's CVS Position: Q2 2018 in Review

Dillon & Associates sold out of CVS Health (CVS) in Q2 2018, closing a stake of 4,160 shares — an estimated $258K sold.

Dillon & Associates first reported a position in CVS in Q1 2016 and held it in 9 quarters. The position peaked at $891K in Q4 2016. 1,573 funds tracked by Wall St. Rank hold CVS as of Q2 2018.

  • Dillon & Associates reported no remaining CVS Health position as of Q2 2018 after selling out during the quarter.
  • Dillon & Associates sold 4,160 CVS Health shares in Q2 2018, an estimated $258K.
  • Dillon & Associates first reported a position in CVS Health in Q1 2016 and held it in 9 quarters.
  • Dillon & Associates's CVS Health position peaked at $891K in Q4 2016.
  • 1,573 funds tracked by Wall St. Rank held CVS Health as of Q2 2018.

Based on Dillon & Associates's 13F filing for Q2 2018, filed 8 Aug 2018.